PREDICTION OF SURVIVAL BASED ON TUMOR SIZE DYNAMICS AND NEW LESIONS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH GEFITINIB OR CARBOPLATIN AND PACLITAXEL.

CLINICAL PHARMACOLOGY & THERAPEUTICS(2019)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要